Kojic acid occupies an interesting space in skincare. It has a reasonable evidence base for brightening and reducing hyperpigmentation, it is natural in origin, and it has been used in Japanese skincare for decades. It is also considerably less potent than hydroquinone (the prescription-strength gold standard for pigmentation) and is somewhat sensitising in some formulations. Understanding both its genuine value and its limits helps you decide where it fits in a routine targeting uneven skin tone.
What kojic acid is and where it comes from
Kojic acid (5-Hydroxy-2-(hydroxymethyl)-4H-pyran-4-one) is a natural chelating agent produced by several fungi, most notably Aspergillus oryzae, in the fermentation of rice, soy, and other starches. It is a byproduct of fermentation processes used in making sake, soy sauce, and miso. This is why kojic acid is specifically associated with Japanese beauty traditions, where rice fermentation has been central to food culture and where the brightening effects of fermented rice byproducts were observed empirically before the specific compound was identified.
How it works on pigmentation
Kojic acid inhibits tyrosinase, a copper-containing enzyme that catalyses the rate-limiting step in melanin synthesis: the conversion of the amino acid tyrosine to L-DOPA and then to melanin precursors. By binding to the copper in the active site of tyrosinase, kojic acid reduces the enzyme’s activity and, over time, reduces melanin production in the skin cells where it is active.
This mechanism is shared with hydroquinone, the most studied and most potent prescription brightening ingredient. The difference is potency: hydroquinone at 4% (prescription) inhibits tyrosinase more powerfully than kojic acid at its typical cosmetic concentrations of 1-2%.
What the clinical evidence shows
Multiple clinical trials have examined kojic acid for melasma, post-inflammatory hyperpigmentation, and solar lentigines (sun spots). The results are generally positive but moderate compared to prescription-strength treatments.
A frequently cited study compared kojic acid 1% combined with glycolic acid 10% to glycolic acid alone over three months. The combined treatment produced significantly greater improvement in hyperpigmentation, which supports the synergistic use of kojic acid with chemical exfoliation.
Another well-designed trial compared kojic acid 2% to hydroquinone 2% and found both produced significant improvements in melasma over 12 weeks, with comparable outcomes at these concentrations. This is encouraging evidence for kojic acid’s efficacy, though at the 4% concentration more commonly prescribed for hydroquinone, the comparison would likely favour hydroquinone.
A 2010 systematic review of kojic acid in dermatology concluded that it is effective for superficial hyperpigmentation with a reasonable safety profile, but noted that the evidence base is smaller and less rigorous than for hydroquinone and azelaic acid.
Concentrations and formulation
In EU cosmetics, kojic acid can be used at concentrations up to 1% with restrictions on the product type. Some markets allow up to 2%. Products marketed at very high concentrations should be treated with some scepticism about both their regulatory compliance and the skin tolerance implications.
Kojic acid is notoriously unstable in formulations. It oxidises on exposure to air, turning yellow or orange, and loses potency in this oxidised state. This is why you may have seen kojic acid products turn colour in the bottle, or why freshly opened products work differently from those halfway through their shelf life. Formulations using stabilised forms, such as kojic dipalmitate (an ester that is more stable and converts to active kojic acid on the skin), maintain potency better.
Packaging matters for kojic acid: opaque or UV-protective packaging with limited air exposure (pump dispensers or airless packaging) better maintains product integrity.
Sensitisation risk
Kojic acid is a known potential allergen and sensitiser. Contact dermatitis from kojic acid is documented and more common in people who have experienced other contact allergies. This tends to manifest as redness, itching, and sometimes a rash at the site of application.
Patch testing before committing to full-face use is particularly advisable for kojic acid, more so than for many other skincare actives. Apply a small amount to the inner arm or behind the ear for a few days before applying to the face.
Sun sensitivity is also relevant. Kojic acid can increase photosensitivity, which is somewhat ironic given its use for sun-induced pigmentation. Using it in the evening rather than the morning and being consistent with daily SPF reduces this concern practically.
Where kojic acid fits in a pigmentation routine
Kojic acid works best as one component of a multi-ingredient approach to hyperpigmentation rather than a standalone treatment. Combining it with vitamin C (which also inhibits tyrosinase through a different mechanism), niacinamide (which inhibits the transfer of melanin to skin cells), and regular AHA exfoliation (which speeds the removal of pigmented surface cells) produces more comprehensive results than any single ingredient alone.
The brightening action of kojic acid, combined with the increased cell turnover from a glycolic or lactic acid product, addresses pigmentation from two directions simultaneously: reducing new melanin production and increasing the rate at which existing pigmented cells are replaced. Clinical evidence supports this combination as more effective than either alone.
Daily SPF is mandatory when treating hyperpigmentation. UV exposure triggers the melanin production that any brightening treatment is trying to reduce. Allowing continued sun exposure while treating pigmentation is working against the treatment in real time.
The realistic expectations
Kojic acid at 1-2% produces visible improvement in superficial hyperpigmentation over 8-12 weeks of consistent use. It is not as fast or as potent as prescription hydroquinone, but it is available without a prescription and has a reasonable safety profile for most people. For mild to moderate post-acne marks and sun-induced pigmentation, it is a legitimate and effective choice in a well-designed routine.
For melasma, which is deeper and more complex, it should be part of a treatment plan ideally guided by a dermatologist, because melasma responds to triggers including UV and hormonal fluctuations that topical treatment alone manages rather than resolves.